NCT05386264View on ClinicalTrials.gov

Autologous Tregs for Aplastic Anaemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 14, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

April 30, 2025

Conditions
Aplastic Anemia
Interventions
OTHER

Expanded autologous T regulatory cells

A 3+3 dose escalation design with expanded T regulatory cells administered on Day 1 and Day 15

Trial Locations (1)

Unknown

RECRUITING

King's College Hospital, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER